Ethical Psychopharmacology is a look at several different aspects of how psychoactive drugs are evaluated, marketed, and promoted by prescribers by looking at issues of transparency, research data, conflict of interest, funding sources and their interests, and informed consent. I will describe the drug approval process through the FDA, history of the DSM and how the diagnostic process has been influenced by money, big Pharma, and conflict of interest. We will look at some clever marketing messages and the difference between marketing and science.